Literature DB >> 34105084

Review of Perineural Invasion in Keratinocyte Carcinomas.

Albert E Zhou1, Karl M Hoegler1, Amor Khachemoune2,3.   

Abstract

Perineural invasion is an infiltrative process of peripheral nerves by the primary neoplasm within the immediate vicinity. Aggressive forms of keratinocyte carcinomas, such as basal cell and squamous cell carcinomas, may feature perineural invasion, which is often associated with tumor recurrence and poorer prognosis. Diagnosis requires a high clinical suspicion. Imaging and histopathology are used to assess for extent of disease while surgical excision with complete circumferential peripheral and margin assessment is the treatment goal. However, there is still significant uncertainty about adjuvant chemotherapy and definitive management guidelines. Here, we summarize the current understanding of this complex pathogenic process, the clinical presentation, and the significance of perineural inflammation. We also discuss the recommendations about staging, prognosis, adjuvant radiotherapy, and general guidelines for managing keratinocyte carcinomas with perineural invasion. A better understanding of perineural invasion is essential to improve diagnosis, tailor interventions, and mitigate patient morbidity and mortality.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Year:  2021        PMID: 34105084     DOI: 10.1007/s40257-021-00615-6

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  89 in total

1.  Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons.

Authors:  Anokhi Jambusaria-Pahlajani; Stephen D Hess; Kenneth A Katz; Daniel Berg; Chrysalyne D Schmults
Journal:  Arch Dermatol       Date:  2010-11

Review 2.  Perineural invasion of cutaneous malignancies.

Authors:  A M Feasel; T J Brown; M A Bogle; J A Tschen; B R Nelson
Journal:  Dermatol Surg       Date:  2001-06       Impact factor: 3.398

3.  Perineural spread by squamous carcinomas of the head and neck: a morphological study using antiaxonal and antimyelin monoclonal antibodies.

Authors:  R L Carter; C S Foster; E A Dinsdale; M R Pittam
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

4.  Perineural lymphatics: myth or fact.

Authors:  D L Larson; A E Rodin; D K Roberts; W K O'Steen; A S Rapperport; S R Lewis
Journal:  Am J Surg       Date:  1966-10       Impact factor: 2.565

Review 5.  Perineural invasion: identification, significance, and a standardized definition.

Authors:  Martin Dunn; Michael B Morgan; Trevor W Beer
Journal:  Dermatol Surg       Date:  2009-02       Impact factor: 3.398

Review 6.  Pathology of Perineural Spread.

Authors:  Ian S Brown
Journal:  J Neurol Surg B Skull Base       Date:  2016-02-26

Review 7.  Mechanisms of Perineural Invasion.

Authors:  Richard L Bakst; Richard J Wong
Journal:  J Neurol Surg B Skull Base       Date:  2016-03-10

8.  Perineural invasion in squamous cell skin carcinoma of the head and neck.

Authors:  H Goepfert; W J Dichtel; J E Medina; R D Lindberg; M D Luna
Journal:  Am J Surg       Date:  1984-10       Impact factor: 2.565

Review 9.  Perineural invasion in cancer: a review of the literature.

Authors:  Catherine Liebig; Gustavo Ayala; Jonathan A Wilks; David H Berger; Daniel Albo
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

10.  Perineural invasion in squamous cell carcinoma of the head and neck.

Authors:  J J Fagan; B Collins; L Barnes; F D'Amico; E N Myers; J T Johnson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-06
View more
  1 in total

1.  Perineural Invasion in Vulvar Squamous-Cell Carcinoma Is an Independent Risk Factor for Cancer-Specific Survival, but Not for Locoregional Recurrence: Results from a Single Tertiary Referral Center.

Authors:  Leonardo Micheletti; Fulvio Borella; Mario Preti; Valentina Frau; Stefano Cosma; Sebastiana Privitera; Luca Bertero; Chiara Benedetto
Journal:  Cancers (Basel)       Date:  2021-12-28       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.